Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial

Launched by UNIVERSITY OF OKLAHOMA · Mar 13, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether screening for atrial fibrillation (AF) can be helpful for older patients who have cancer. Atrial fibrillation is a heart condition that can lead to serious complications, and we know that patients with cancer are more likely to have it. The goal of this trial is to see if checking for AF in cancer patients can help detect it early, which might lead to better treatment options and outcomes.

To be eligible for the trial, participants must be at least 65 years old and have either a current diagnosis or a history of cancer. This includes those who are receiving or have received treatments like chemotherapy, radiotherapy, or cancer surgeries. However, individuals with a known history of atrial fibrillation or those who do not speak English will not be included. If you join the trial, you can expect to undergo screening for AF and be part of a study that aims to improve care for cancer patients. The trial is currently recruiting participants, so it’s a good opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Male and female patients age ≥65 with a current diagnosis or history of cancer.
• • 2. Patients currently undergoing or history of chemotherapy, radiotherapy or cancer related surgeries will be included.
• • 3. The age is restricted to ≥65 years because prevalence of AF is extremely low. .
• Exclusion Criteria:
• • 1. Known history of atrial fibrillation.
• • 2. Non-English-speaking participants will not be enrolled